The site will house around 3,000 people – including GSK's global leadership team ... "As a global biopharma company, we are proud to call London our home and look forward to the opportunities ...

GSK’s site will house 30 scientists and engineers who will ... CEO Emma Walmsley told the London Evening Standard that she hoped the project will contribute to London’s “tech talent pool ...

GSK’s shares rose as much as 6.7% in London, the most on an intraday basis since October. They’ve been held back by concern ...

Pfizer denied the allegations and argued GSK's patents were invalid. It convinced a London court to invalidate related UK patents owned by GSK in a separate case last year. GSK has also sued ...